Invest Now
Products +
Pricing
Trading & Investing +
Calculators +
Support +
Learn +
IPO +
Partner
About us +
#AndekhaSach New
Login Open an account
Samco securities limited
Samco Star Rating Ads

Indrayani Biotech Ltd Share Price

₹ 0 (%)

Updated on 01-01-1970 5:30 AM

Stock Rating

Pros 1

 

Cons 8

Indrayani Biotech Ltd Price Performance

  • Day's Low
  • ₹0
  • Day's High
  • ₹0
₹ 0
  • 52-w low
  • ₹0
  • 52-w high
  • ₹0
0
  • Day's open
    ₹0
  • Previous close
    ₹0
  • VWAP
    ₹0
  • Lower price band
    ₹0
  • Upper price band
    ₹0

Today's Market Action

Its last traded stock price on BSE was 36.50 up by 0.86%. The total volume of shares on NSE and BSE combined was 37,223 shares. Its total combined turnover was Rs 0.14 crores.

Indrayani Biotech Ltd Medium and Long Term Market Action

The stock price of Indrayani Biotech Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Indrayani Biotech Ltd Fundamentals

  • Market Cap (Cr): 193

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Indrayani Biotech Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Indrayani Biotech Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Indrayani Biotech Ltd

Data not available.

Indrayani Biotech Ltd FAQ's

What is Share Price of Indrayani Biotech Ltd?

What is the Market Cap of Indrayani Biotech Ltd?

What is PE Ratio of Indrayani Biotech Ltd?

What is PB Ratio of Indrayani Biotech Ltd?

What is the CAGR of Indrayani Biotech Ltd?

How to Buy Indrayani Biotech Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Great Cash Conversion of Profits
    The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 276.96% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 1.17 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.71. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 129 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • Poor Corporate Governance
    The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.
  • High Promoter Pledge
    The company has a relatively high promoter pledge to the extent of 15% of the total company's shareholding which can have a significantly negative impact on stock.

Valuation Analysis

Margin of safety
(19/12/2024)
Stock Valuation
Green line
93
71.43%
71.43% People are bullish about Indrayani Biotech Ltd
28.57%
28.57 % People are bearish about Indrayani Biotech Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Indrayani Biotech Ltd

₹ 0 (%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      ×

      Filing Complaints on SCORES

      Easy & quick Easy & quick

      1. Register on SCORES portal

      2. Mandatory details for filling complaints on SCORES

      Name | PAN | Address | Mobile | Number | E-mail ID

      3. Benefits

      Effective Communication

      Speedy redressal of the grievances

      Website Icon
      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91